12 completed, 6 terminated, 2 withdrawn. 20 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 20 | Completed 12, Terminated 6, Withdrawn 2 |
| Phase 2 | 5 | Completed 4, Terminated 1 |
Follow Reverse Transcriptase Polymerase Chain Reaction: new trials by email Literature Review of Reverse Transcriptase Polymerase Chain Reaction trials Research Report on Reverse Transcriptase Polymerase Chain Reaction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia laboratory biomarker analysis, western blotting, gene expression analysis - Refractory Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia | Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2010-12-01 | 2014-01-13 | |
| Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy panobinostat, fluorouracil, leucovorin calcium - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Terminated | University of Southern California | 7 | 2010-10-01 | 2015-05-27 |
| Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer letrozole, panobinostat, RNA analysis - Breast Cancer | Phase 1 / Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 28 | 2010-09-01 | 2017-06-27 |
| Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma azacitidine, lenalidomide, dexamethasone - Refractory Multiple Myeloma | Phase 1 / Phase 2 | Completed | Case Comprehensive Cancer Center | 45 | 2010-06-01 | 2020-11-16 |
| 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes 5-fluoro-2-deoxycytidine, tetrahydrouridine, laboratory biomarker analysis - Adult Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes | Phase 1 | Completed | City of Hope Medical Center | 25 | 2009-12-22 | 2026-10-16 |
| Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery systemic chemotherapy, RNA analysis, gene expression analysis - Colorectal Cancer | Phase 1 | Withdrawn | Barbara Ann Karmanos Cancer Institute | 2009-06-01 | 2013-04-16 | |
| Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer decitabine, NY-ESO-1 peptide vaccine, pegylated liposomal doxorubicin hydrochloride - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 | Completed | Roswell Park Cancer Institute | 18 | 2009-04-01 | 2022-08-01 |
| Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy Ad5-CMV-NIS, Liothyronine Sodium, Reverse Transcriptase Polymerase Chain Reaction - Prostate Cancer | Phase 1 | Terminated | Mayo Clinic | 8 | 2008-11-03 | 2026-07-22 |
| Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery sunitinib malate, gene expression analysis, reverse transcriptase-polymerase chain reaction - Kidney Cancer | Phase 1 | Terminated | Harry Drabkin | 17 | 2008-10-01 | 2015-10-22 |
| Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia dasatinib, vorinostat, cytogenetic analysis - Leukemia | Phase 1 | Completed | City of Hope Medical Center | 5 | 2008-09-01 | 2012-07-17 |
| Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma DI-Leu16-IL2 immunocytokine, rituximab, flow cytometry - Anaplastic Large Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma | Phase 1 | Completed | City of Hope Medical Center | 9 | 2008-03-17 | 2026-10-23 |
| PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer PEG-interferon alfa-2b, Sorafenib, gene expression analysis - Kidney Cancer | Phase 1 | Terminated | Thomas Olencki | 1 | 2008-02-01 | 2015-06-08 |
| Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes clofarabine, melphalan, gene expression analysis - Leukemia, Myelodysplastic Syndromes | Phase 1 | Completed | City of Hope Medical Center | 20 | 2007-07-27 | 2026-10-19 |
| Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx carboplatin, cisplatin, docetaxel - Head and Neck Cancer | Phase 1 / Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 7 | 2007-05-01 | 2018-07-09 |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery riluzole, protein expression analysis, reverse transcriptase-polymerase chain reaction - Melanoma (Skin) | Phase 1 | Terminated | University of Medicine and Dentistry of New Jersey | 15 | 2007-02-01 | 2009-12-11 |
| AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors AEG35156, docetaxel, protein expression analysis - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | NCIC Clinical Trials Group | 27 | 2006-07-27 | 2023-08-04 |
| Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma nelfinavir mesylate, biopsy, laboratory biomarker analysis - Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 29 | 2006-03-01 | 2015-04-01 |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors lapatinib ditosylate, vinorelbine ditartrate, comparative genomic hybridization - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | University of California, Davis | 22 | 2005-12-01 | 2012-04-19 |
| Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors bortezomib, pemetrexed disodium, gene expression analysis - Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 / Phase 2 | Completed | University of California, Davis | 27 | 2005-03-01 | 2018-10-31 |
| Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer carcinoembryonic antigen-expressing measles virus, oncolytic measles virus encoding thyroidal sodium iodide symporter, reverse transcriptase-polymerase chain reaction - Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | Completed | Mayo Clinic | 37 | 2004-04-19 | 2024-01-16 |
Carcinoma, Ovarian Epithelial (2) · Carcinoma, Renal Cell (2) · Kidney Neoplasms (2) · Leukemia (2) · Leukemia, Myeloid, Acute (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Rectal Neoplasms (2) · Blast Crisis (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Brenner Tumor (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Congenital Abnormalities (1)
City of Hope Medical Center (5) · Mayo Clinic (2) · Roswell Park Cancer Institute (2) · University of California, Davis (2) · Alliance for Clinical Trials in Oncology (1) · Barbara Ann Karmanos Cancer Institute (1) · Case Comprehensive Cancer Center (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Harry Drabkin (1) · NCIC Clinical Trials Group (1) · Thomas Olencki (1) · University of Medicine and Dentistry of New Jersey (1) · University of Southern California (1)
United States (16) · Belgium (1) · Canada (1)
Ahmad Awada, MD, PhD (1) · Angela Davies, MD (1) · Anthony Stein, MD (1) · Asher Chanan-Khan (1) · Bhaumik B. Patel, MD (1) · Brian J. Davis, M.D. (1) · David Snyder, MD (1) · Ehsan Malek, MD (1) · Evanthia Galanis, MD (1) · Frederic Reu (1) · Gerald Batist, MD (1) · Harry A. Drabkin, MD (1) · Heinz-Josef Lenz (1) · Helen K. Chew, MD (1) · James S. Goydos, MD (1)
PMID 18090584, PMID 22989664, PMID 26774555
P30CA033572 (2), P30CA015083 (1), P30CA072720 (1), P30CA093373 (1), P50CA091956 (1), P50CA107399 (1), P50CA136393 (1)